ICD-10-CM Billable Code

H71.9

Unspecified cholesteatoma

Clinical Classification Guidelines

Medical Intelligence & Overview

Unspecified cholesteatoma is a benign or non-cancerous growth that occurs in the middle ear. It involves the abnormal skin cell buildup, which can cause damage to the ear's structures over time. Often associated with infections or chronic ear problems, this condition can lead to hearing loss and other complications if not appropriately managed. The term 'unspecified' indicates that specific details about the location or extent of the cholesteatoma have not been documented, making it a general diagnosis under ICD-10 code H71.9.

Causes & Symptoms

Clinical Causes: Chronic ear infections leading to persistent inflammation Eustachian tube dysfunction impairing normal ear drainage Previous ear injuries or surgeries Congenital abnormalities present from birth Recurrent middle ear infections (otitis media)

Key Symptoms: Hearing loss or muffled hearing Ear fullness or pressure sensation Pure tone sounds may be distorted Discharge from the ear, sometimes foul-smelling Dizziness or balance issues Ear pain or discomfort Possible facial muscle weakness if the growth affects nerves

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and specialized tests. An otolaryngologist (ear, nose, and throat specialist) will examine the ear using an otoscope to look for characteristic signs like debris or abnormal skin growths. Imaging studies such as CT scans are valuable for assessing the size, extent, and location of the cholesteatoma, helping to plan appropriate treatment strategies. Audiometric testing may be conducted to evaluate the degree of hearing loss associated with the condition.

Treatment Protocols: Treatment options aim to remove the cholesteatoma and prevent further damage. Surgical procedures are often necessary to excise the growth and repair any damaged structures within the ear. The type of surgery depends on the size and location of the cholesteatoma. Postoperative care may include antibiotics to control infections and regular follow-up appointments to monitor for recurrence. In some situations, audiologic rehabilitation may be recommended to address hearing impairments after treatment.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H71.9 a billable ICD-10 code?
Yes, H71.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H71.9?
Clinical documentation must specify the nature of Unspecified cholesteatoma and any associated comorbidities for accurate reporting.

Cite this Clinical Reference